On the effect of neonatal nitric oxide synthase inhibition in rats: A potential neurodevelopmental model of schizophrenia

Neuropharmacology

Volumn 38, Issue 9, 1999, Pages 1299-1306

  Black, Mark D ^a   Selk, David E ^a   Hitchcock, J M ^a   Wettstein, Joseph G ^a   Sorensen, Stephen M ^a  

^a SANOFI   (France)

Author keywords

NADPH d; Neonatal; Neurodevelopmental; Nitric oxide; Schizophrenia; Sex differences

Indexed keywords

AMPHETAMINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENCYCLIDINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME INHIBITION; FEMALE; MALE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SEX DIFFERENCE; STARTLE REFLEX; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; MALE; MOTOR ACTIVITY; NADPH DEHYDROGENASE; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; SEX CHARACTERISTICS;

EID: 0032812198     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00041-6     Document Type: Article

References (65)

1. Akbarian S., Bunney W.E. Jr, Potkin S.G., Wigal S.B., Hagman J.O., Sandman C.A., Jones E.G. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiat. 50(3):1993;169-177.
2. Akbarian S., Vinuela A., Kim J.J., Potkin S.G., Bunney W.E. Jr, Jones E.G. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch. Gen. Psychiatry. 50(3):1993;178-187.
3. Beatty W.W., Holzer G.A. Sex differences in stereotyped behavior in the rat. Pharmacol. Biochem. Behav. 9:1978;777-783.
4. Bell D.S. Comparison of amphetamine psychosis and schizophrenia. Br. J. Psychiatry. 111:1965;701-707.
5. Bhagat K., Vallance P. Nitric oxide 9 years on. J.R. Soc. Med. 89(12):1996;667-673.
6. Black M.D., Lister S., Hitchcock J.M., Giersbergen P., Sorensen S.M. Neonatal hippocampal lesion model of schizophrenia in rats: sex differences and persistence of effects into maturity. Drug Dev. Res. 43:1998;206-213.
7. Black M.D., Matthews E.K., Humphrey P.P. The effects of a photosensitive nitric oxide donor on basal and electrically-stimulated dopamine efflux from the rat striatum in vitro. Neuropharmacology. 33(11):1994;1357-1365.
8. Bloom F.E. Advancing neurodevelopmental origin for schizophrenia. Arch. Gen. Psychiatry. 50:1993;224-227.
9. Bogarts B. Recent advances in the neuropathology of schizophrenia. Schizophr. Bull. 19:1993;431-445.
10. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15(4):1978;339-343.
11. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry. 49(3):1992;206-215.
12. Bravo H., Inzunza O., Fernandez V., Sanhueza M. Distribution of NADPH-d positive neurons during postnatal development of the rat somatosensory cortex correlates with gradients of neurogenesis and development. Neurosci. Lett. 234(2-3):1997;103-106.
13. Bredt D.S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8(1):1992;3-11.
14. Castle D.J., Abel K., Takei N., Murray R.M. Gender differences in schizophrenia: hormonal effect or subtypes? Schizophr. Bull. 21(1):1995;1-12.
15. Castellani S., Adams P.M. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur J. Pharmacol. 73(2-3):1981;143-154.
16. Castner S.A., Xiao L., Becker J.B. Sex differences in striatal dopamine: in vivo microdialysis and behavioural studies. Brain Res. 610:1993;127-143.
17. Cornford E.M., Cornford M.E. Nutrient transport and the blood-brain barrier in developing animals. Fed. Proc. 45(7):1986;2065-2072.
18. Dawson T.M., Bredt D.S., Fotuhi M., Hwang P.M., Snyder S.H. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. 88(17):1991;7797-7801.
19. Deutsch S.I., Rosse R.B., Paul S.M., Tomasino V., Koetzner L., Morn C.B., Mastropaolo J. 7-nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. Neuropsychopharmacology. 15(1):1996;37-43.
20. Dwyer M.A., Bredt D.S., Snyder S.H. Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo. Biochem. Biophy. Res. Comm. 176(3):1991;1136-1141.
21. Erard R., Luisada P.V., Peele R. The PCP psychosis: prolonged intoxication or drug-precipitated functional illness? J. Psychedelic Drugs. 12(3-4):1980;235-251.
22. Gally J.A., Montague P.R., Reeke G.N. Jr, Edelman G.M. The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc. Natl. Acad. Sci. 87(9):1990;3547-3551.
23. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14(2):1991;60-67.
24. Hambrecht M., Maurer K., Hafner H., Sartorius N. Transnational stability of gender differences in schizophrenia. Eur. Arch. Psychiatry Neurol. Sci. 242:1992;6-12.
25. Hess D.T., Patterson S.I., Smith D.S., Skene J.H. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature. 366(6455):1993;562-565.
26. Hindley S., Juurlink B.H., Gysbers J.W., Middlemiss P.J., Herman M.A., Rathbone M.P. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J. Neurosci. Res. 47(4):1997;427-439.
27. Holscher C. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci. 20(7):1997;298-303.
28. Hope B.T., Michael G.J., Knigge K.M., Vincent S.R. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 88(7):1991;2811-2814.
29. Hu J., Lee J.H., El-Fakahany E.E. Inhibition of neuronal nitric oxide synthase by antipsychotic drugs. Psychopharmacology. 114(1):1994;161-166.
30. Itil T., Keskiner A., Kiremitci N., Holden J.M. Effect of phencyclidine in chronic schizophrenics. Can. Psychiatr. Assoc. J. 12(2):1967;209-212.
31. Janowski D.S., El-Youset M.K., Davis J.M., Sekerke K.J. Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch. Gen. Psychiatry. 28:1973;185-191.
32. Johansson C., Jackson D.M., Svensson L. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology. 131(2):1997;167-173.
33. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148(10):1991;1301-1308.
34. Joseph M.H., Frith C.D., Waddington J.L. Dopaminergic mechanism and cognitive deficits in schizophrenia. Psychopharmacology (Berlin). 63:1979;273-280.
35. Kramer J.C., Fischman V.S., Littlefield D.C. Amphetamine abuse. Pattern and effects of high doses taken intravenously. J. Am. Med. Assoc. 201(5):1967;305-309.
36. Lewine R.R.J. Gender and schizophrenia. Nasrallah H.A. Handbook of Schizophrenia, vol. 3. 1988;379-397 Elsevier, Amsterdam.
37. Liberman R.P. Psychosocial treatments for schizophrenia. Psychiatry. 57(2):1994;104-114.
38. Lipska B.K., Chrapusta S.J., Egan M.F., Weinberger D.R. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse. 20:1995;125-130.
39. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential model of schizophrenia. Neuropsychopharmacology. 9:1993;67-75.
40. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122:1995;35-43.
41. Lipska B.K., Weinberger D.R. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Dev. Brain Res. 75:1993;213-222.
42. Lipska B.K., Weinberger D.R. Gonadectomy does not prevent novelty or drug-induced motor hyperresponsiveness in rats with neeonatal hippocampal damage. Dev. Brain Res. 78:1994;253-258.
43. Lipska B.K., Weinberger D.R. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology. 10:1994;199-205.
44. Lipska B.K., Weinberger D.R. Genetic variation in vulnerability to the behavioural effects of neonatal hippocampal damage in rats. Proc. Natl. Acad. Sci. 92:1995;8906-8910.
45. Lonart G., Wang J., Johnson K.M. Nitric oxide induces neurotransmitter release from hippocampal slices. Eur. J. Pharmacol. 220(2-3):1992;271-272.
46. Luby E.D., Cohen B.D., Rosenbaum G., Gottlieb J.S., Kelley R. Study of a new schizophrenomimetic drug - Sernyl. Am. Med. Assoc. Arch. Neurol. Psychiatry. 81:1959;363-369.
47. Marengo J. Classifying the courses of schizophrenia. Schizophr. Bull. 20:1994;519-536.
48. Mayer B., Schmidt K., Humbert P., Bohme E. Biosynthesis of endothelium-derived relaxing factor: a cytosolic enzyme in porcine aortic endothelial cells Ca2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem. Biophys. Res. Comm. 164(2):1989;678-685.
49. Nelson R.J., Demas G.E., Huang P.L., Fishman M.C., Dawson V.L., Dawson T.M., Snyder S.H. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature. 378:1995;383-386.
50. Ogilvie P., Schilling K., Billingsley M.L., Schmidt H.H. Induction and variants of neuronal nitric oxide synthase type I during synaptogenesis. FASEB J. 9(9):1995;799-806.
51. Sahakian B.J., Robbins T.W., Morgan M.J., Iversen S.D. The effects of psychomotor stimulants on stereotypy and locomotor activity in socially-deprived and control rats. Brain Res. 84(2):1975;195-205.
52. Sams-Dodd F. Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav. Pharmacol. 7:1996;3-23.
53. Savageau M.M., Beatty W.W. Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats. Pharmacol. Biochem. Behav. 14:1981;17-21.
54. Seeman M.V., Lang M. The role of estrogens in schizophrenia gender differences. Schizophr. Bull. 16(2):1990;185-190.
55. Siegel R.K. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. NIDA Res. Monogr. 21:1978;119-147.
56. Snyder S.H. Amphetamine psychosis: a 'model' schizophrenia mediated by catecholamines. Am. J. Psychiatry. 130(1):1973;61-67.
57. Snyder S.H., Bredt D.S. Nitric oxide as a neuronal messenger. Trends Pharmacol. Sci. 12(4):1991;125-128.
58. Tamminga, C.A., 1997. Gender and schizophrenia. J. Clin. Psychiatry 58 (Suppl. 15), 33-37.
59. Tomic D., Zobundzija M., Meaugorac M. Postnatal development of nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d) positive neurons in rat prefrontal cortex. Neurosci. Lett. 170(2):1994;217-220.
60. Vaid R.R., Yee B.K., Shalev U., Rawlins J.N., Weiner I., Feldon J., Totterdell S. Neonatal nonhandling and in utero prenatal stress reduce the density of NADPH-diaphorase-reactive neurons in the fascia dentata and Ammon's horn of rats. J. Neurosci. 17(14):1997;5599-5609.
61. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660-669.
62. Weinberger D.R., Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res. 16:1995;87-110.
63. Wortwein G., Gustafson B., Hansen K.L., Mogensen J. Behavioral symptoms in adult rats after postnatal L-nitro-arginine. Int. J. Dev. Neurosci. 15(2):1997;147-154.
64. Wu H.H., Waid D.K., McLoon S.C. Nitric oxide and the developmental remodeling of retinal connections in the brain. Prog. Brain Res. 108:1996;273-286.
65. Yan X.X., Garey L.J., Jen L.S. Development of NADPH-diaphorase activity in the rat neocortex. Brain Res. Dev. Brain Res. 79(1):1994;29-38.